Clinical Trials Directory

Trials / Unknown

UnknownNCT05026892

Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
1,200 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Factors associated with severe forms of COVID-19 infection in patients with inflammatory rheumatic diseases (IRD) or Autoimmune Diseases (AID) are unknown. This unprecedented situation leads to empirical and potentially erroneous advice and recommendations for care. Identifying factors associated with severity, in the context of this pandemic, which is expected to last many months, and possibly years, is crucial for future patients. The objective of this work is to identify the factors associated with the occurrence of severe forms of COVID-19 infection in patients with IRD or AID, by combining analysis of 2 large databases.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention, only collection of data

Timeline

Start date
2021-08-01
Primary completion
2021-12-01
Completion
2022-07-01
First posted
2021-08-30
Last updated
2021-08-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05026892. Inclusion in this directory is not an endorsement.